arrow
K

Kian Fan Chung

imperial college london
H指数:142
被引数:8.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stool and Airway Microbiome Signatures Associated With Treatment Response to Dupilumab in Severe Asthma: Findings From the PRISM Study

严重哮喘患者对Dupilumab治疗反应相关的粪便和气道微生物组特征:PRISM研究的结果

2026-09-230
PRE
Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma

哮喘持续时间较长与重症哮喘中升高的非T2痰生物标志物和降低的T2炎症相关

2026-07-280
OAAI
EAACI Guidelines on Environmental Science for Allergy and Asthma—Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy

欧洲过敏与临床免疫学会关于环境科学对过敏和哮喘的指南——基于证据的建议:为预防及公共卫生行动以减轻花粉暴露对呼吸道过敏的影响

2026-06-260
PRE
Clinical Features of Cellular Senescence Pathways in Severe Asthma

严重哮喘中细胞衰老通路临床特征

2026-06-180
OAAI
Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model

1-甲基烟酰胺循环水平预测Dupilumab对成人哮喘的疗效:一项预测模型

2026-05-060
PRE
Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules

慢性炎症性疾病中非生物和基于RNA的疗法的更新: 通过小分子的精准医学

2026-02-070
OAAI
Nasal gene expression shows a distinct signature in T2-high asthma but not in T2-low disease

鼻基因表达在T2-high哮喘中显示出独特的特征,但在T2-low疾病中则不然。

2026-01-020
OAAI
Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma
2025-12-010
PRE